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  Abstract: Developmental programming refers to processes that occur during early life, 
which may have long-term consequences, modulating adult health and disease. Complex 
diseases, such as diabetes, cancer and cardiovascular disease, have a high prevalence in 
different populations, are multifactorial, and may have a strong environmental component. 
The environment interacts with organisms, affecting their behavior, morphology and 
physiology. This interaction may induce permanent or long-term changes, and organisms 
may be more susceptible to environmental factors during certain developmental stages, 
such as the prenatal and early postnatal periods. Several factors have been identified as 
responsible for inducing the reprogramming of various reproductive and non-reproductive 
tissues. Among them, both natural and synthetic steroids, such as endocrine disruptors, are 
known to have either detrimental or positive effects on organisms depending on the dose of 
exposure, stage of development and biological sexual background. The present review 
focuses on the action of steroids and endocrine disruptors as agents involved in 
developmental programming and on their modulation and effects on female 
neuroendocrine functions. 
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1.-Introduction 
Certain developmental stages, such as the prenatal and early postnatal periods of an 
organism’s life, are windows of susceptibility during which the environment can have a 
major impact on the embryo or the infant and might regulate the health status during adult 
life [1]. During those windows of susceptibility, different factors such as the lifestyle, diet, 
environmental pollutants, medical and pharmaceutical interventions may affect organisms, 
altering their development [2] (Figure 1). Developmental programming refers to processes 
by which stimuli or insults produce permanent effects on the structure and functions of the 
organism, which could be due to epigenetic mechanisms or stable changes in gene 
expression [3-5]. Developmental plasticity is a phenomenon that allows a developing 
organism to change its structure and function in response to environmental cues. The 
Developmental Origins of Health and Disease (DOHaD) hypothesis, which is based on animal 
models and epidemiological evidence from several multifactorial and complex pathologies 
such as obesity, diabetes, polycystic ovary syndrome (PCOS) and neuronal disorders [6], 
describes how early life experience influences the health and disease risk later in life [2].  
 
Steroids are lipophilic molecules that participate in the regulation and establishment of the 
hypothalamus-pituitary-gonadal axis, in the case of gonadal steroids (such as testosterone 
(T) and 17-B-estradiol (E2)), and the hypothalamus-pituitary-adrenal axis, in the case of 
glucocorticoids. Due to the lipophilic nature of these compounds, most of them and their 
metabolites may be able to cross the blood-brain barrier as well as the placenta during 
prenatal life [7].  
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Gonadal steroids and glucocorticoids are synthesized mainly by the gonads and adrenal 
glands, during gestation, also by the fetoplacental unit. These hormones are all derived from 
cholesterol and the many enzymes involved in their synthesis are strictly regulated. The first 
step in steroid synthesis involves the formation of pregnenolone. Then, two different 
pathways may lead either to progesterone, which acts as a precursor for the synthesis of 
androgens, estrogens and glucocorticoids, or to 17-alpha-hydroxypregnenolone, which leads 
to the formation of androgens and estrogens. Estrogen production depends on androgens 
as substrates (Figure 2). All these compounds share a common structure and their formation 
is dependent on pituitary hormone signaling in the different target tissues.  
 
Several studies have described that male and female susceptibility to different complex 
diseases is not the same [8-10] and that parental life experience could affect offspring 
development, particularly due to maternal effects [11, 12]. As steroids play several roles in 
sexual development and in the maintenance of biological differences, here we propose to 
review the effects of steroids as actors involved in the effects of developmental 
programming on the female neuroendocrine system. 
 
2.- Gonadal steroids 
2.1-Androgens and PCOS as a clinical case 
In females, androgens play an important role in the regulation of fertility. Although they had 
been assumed to be detrimental or dispensable in normal folliculogenesis and ovarian 
functions, in the past years, they have been shown to have positive functions on these 
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processes as they are expressed at all stages of follicular development [13]. It has been 
shown that alterations in androgen levels may be involved in disorders such as PCOS, 
endometrium cancer and endometriosis [14]. T, which is the main androgen, exerts its 
actions mainly through the androgen receptor (AR), but it can also induce biological effects 
through its main active metabolites: dihydrotestosterone and E2. Dihydrotestosterone also 
binds to AR but its action is more potent and E2 can act by its own receptors [15].  
In women, androgens are produced in the ovaries and adrenal glands. The most important 
androgens are T and androstenedione, but females also produce dehydroepiandrosterone 
and dehydroepiandrosterone sulfate, which are weaker androgens [16]. T is important for 
mammalian brain development [10]. Although T levels in females are higher during fetal life 
than in adulthood, male fetuses always show higher T levels than females during early 
development [17]. Androgens play important roles during prenatal life and in the early 
postpartum period, being fundamental for brain development and sexual differentiation 
[17-19]. Both sexes express the AR, but during development, there is a lack of androgens in 
females, which leads to the formation of the genital tubercle into a clitoris and the 
urogenital swellings into the labia majora [20]. Studies in different animal models have 
shown that, during late embryonic life and early postnatal life, there is a window of 
programming that is susceptible to androgens, and that these affect sexual organ function, 
brain structure and behavior. It has also been seen that puberty is another window of 
susceptibility and that androgens (as well as estrogens) affect body composition, by 
affecting muscle build up, but not genitalia [20]. In post-natal life, androgens play a key role 
in women reproduction, not only because they act as estrogen precursors but also because 
they are key for ovarian follicle development [21]. 
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In 1959, Phoenix et al. [22] showed that prenatal treatment of guinea pig females with T had 
long-term effects on behavior as well as on phenotypic reproductive outcomes. T exposure 
in females has been related to several alterations. Among them, one of the most important 
is PCOS, an endocrine-metabolic disorder that affects 5-10% of women of reproductive age. 
This disorder is characterized by menstrual irregularities (oligomenorrhea or amenorrhea) 
and clinical and/or biochemical hyperandrogenism in the presence or absence of polycystic 
ovaries, with more than half of the patients being overweight or obese [23].  
 
PCOS is considered a multifactorial pathology but its etiology remains controversial. Current 
theories emphasize on genetic and intrauterine origins coupled with environmental factors 
such as diet and altered lifestyle patterns [24]. As gene candidates for PCOS can explain only 
part of the heritability of the syndrome, an environmental role and an epigenetic 
contribution have also been suggested. It has been reported that prenatal androgen 
exposure is able to induce polycystic ovaries features in rats [25-27], mice [28], monkeys 
[29, 30] and sheep [31], and that fetal programming, mediated by prenatal 
hyperandrogenism, is related to hyperinsulinemia, dyslipidemia, insulin resistance, 
cardiovascular disease and metabolic syndrome, all of which are found in high incidence in 
women with PCOS [25, 26, 32, 33].  
 
It has been proposed that PCOS mothers may give birth to children who may show 
alterations in their metabolic and reproductive characteristics [34-36]. Different studies 
have shown that both daughters and sons from PCOS mothers show an altered metabolic 
function [34, 36, 37]. Nevertheless, reproductive disruptions have only been found in PCOS 
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women`s daughters, showing evidence of an increased follicular mass, and higher luteinizing 
hormone (LH) and T levels at the end of puberty [37].  
 
In animal models it has been shown that prenatal and neonatal androgen excess can lead to 
the development of PCOS like features. Hyperandrogenism leads to reproductive changes in 
females during pubertal and adult life, causing alterations in follicular development, ovarian 
steroidogenesis, uterine features and changes in behavior. Androgen excess also leads to 
metabolic alterations, affecting the liver, adipose tissue and other organs [25-27, 38-41]. 
 
Although there are controversial results about the levels of LH and follicle stimulating 
hormone (FSH) in PCOS patients, many patients present LH hypersecretion, which can be 
blunted in the adult patient due to increased Body Mass Index (BMI). In addition, after 
leuprolide stimulation, 2-3-month-old PCOS daughters show increased LH secretion [42]. 
This effect disappears during childhood when the hypothalamus-gonadal axis is dormant 
and reappears at the end of puberty [37]. In contrast, in the sheep model, the increased LH 
secretion in the offspring of androgenized mothers seems to be related to the metabolic 
component that appears later in life and is not modulated by prenatal interventions [43]. 
The fact that animal models do not replicate all human PCOS traits makes it difficult to fully 
understand PCOS pathogenic mechanisms. Abbott et al. (2017) have recently reported the 
existence of a hyperandrogenic population of female rhesus monkeys that exhibit PCOS 
traits [44]. These findings suggest that the syndrome may have a possible ancient origin and 
that its features may naturally affect other species beyond humans, and remark the role of 
androgens in female biology. Besides, in laboratory conditions, gestational exposure of 
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female monkeys to androgens induces several PCOS-like neuroendocrine, reproductive and 
metabolic features in adult life [44]. These findings, together with the fact that rhesus 
monkeys share over 90% of their genome with humans, are consistent with the hypothesis 
that PCOS pathogenesis is determined not only by genetic components but also by 
epigenetic mechanisms, in which androgens play a major role during development [44].  
 
In most of these models, the third trimester of pregnancy seems to be the most important 
window of programming (Figure 3). PCOS mothers treated with metformin throughout 
pregnancy improve their hormonal and metabolic parameters during the third trimester and 
their female offspring lack the markers of ovarian programming observed in the non-treated 
PCOS group [42]. Thus, appropriate management of these pregnancies seems to be key to 
avoid the perpetuation of this condition. On the other hand, in rodent models, the first 
postnatal days of life are also a window of susceptibility for programming, as androgen 
administration in the first days of life may also lead to long-term alterations and the 
appearance of PCOS-like features [45]. Taken together, these results highlight the 
importance of androgens in females and suggest that the levels of androgens are tightly 
regulated during development, as alterations in their levels during prenatal or early 
postnatal life lead to long-term consequences that affect both reproduction and 
metabolism.  
2.2-Estrogens 
In the steroidogenic process, the aromatization of androgens results in estrogens. The most 
abundant and potent estrogen in females is E2. E2 acts mainly through the estrogen receptor 
(ER), which has two different isoforms known as alpha (ERα) and beta (ERβ), but may also 
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act through GPER, a G-protein-coupled membrane receptor [15, 46]. Estrogens have 
multiple metabolic actions that take part via their target tissues. They can influence glucose 
homeostasis in the liver, adipose tissue and skeletal muscle [47]. In the pancreas, they can 
influence insulin secretion, whereas, at the hypothalamic level, they may modulate food 
intake [47]. They are of great importance in female reproductive functions. In mammals, 
ovarian folliculogenesis is a process dependent on E2 bioavailability, and E2 contributes to 
the maintenance of pregnancy and controls the release of gonadotropins at hypothalamic 
level [48].  
 
As E2 plays different functions, it has been proposed that it may play a modulatory effect 
during development. Thus, alterations in its levels may lead to consequences during 
postnatal life. Most studies regarding this point have shown that E2 has a potent action in 
rodents and other animal models such as sheep, during the first days of postnatal life when 
the ovarian follicle population is established, and that it can also lead to PCOS-like features 
in adult life [41, 49-51] (Figure 3). Puttabyatappa et al. (2016) [52] showed that prenatal E2 
administration in sheep does not reproduce the neuroendocrine disruptions caused by T. 
This shows that the effects of T on programming reproductive alterations may be caused by 
androgenic effects during prenatal life [53], and/or that androgens act via estrogenic 
pathways due to T aromatization [41, 52]. Puttabyatappa et al. (2016) [52] also mentioned 
that the dose of E2 administered was not enough to generate a disruption. Thus, prenatal 
estrogenic effects are yet to be explored. As many pollutant components act as estrogenic-
like compounds, several authors have explored the action of estrogens during development 
and the windows of susceptibility during fetal life.  
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More is known about the estrogenic action during early postnatal life. Sotomayor et al. 
(2008) [54] have shown that a single injection of estradiol valerate on postnatal day 1 alters 
the estrous cycle, lead to the development of polycystic ovaries with a reduction of 
primordial and preantral follicles, and increases androgen biosynthesis. These authors also 
found that this treatment leads to alterations in body weight gain. In other studies, they 
have shown that the action of estradiol valerate may involve ovarian sympathetic activity 
and hypothalamus alterations that affect reproductive functions and ovarian development 
[54, 55].   
 
Taken together, these results suggest that although androgens and estrogens may induce 
developmental programming in females and lead to long-term detrimental effects in both 
metabolic and reproductive functions, the susceptibility window for each of them seems to 
be different. According to the evidence from animal models, females seem to be more 
susceptible to androgens during prenatal life and more susceptible to estrogens during early 
post-natal life.  
 
2.3- Gonadal steroids and their neuroendocrine effect on the predisposition to drug 
addiction 
Androgens and estrogens play important roles in the central nervous system. In females, 
they can alter reproductive and metabolic pathways through the modulation of 
hypothalamic and pituitary processes, i.e. by modulating the release of gonadotropins and 
acting as neuromodulators in the dopaminergic system. It has also been shown that 
androgens and estrogens can alter behavior and susceptibility to certain drugs and alcohol 
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as they act on the dopaminergic system [15]. Although both males and females may become 
addicted to drugs, females may initiate drug use at earlier ages, show enhanced responses 
to drugs of abuse, be more vulnerable to addictions, and experience more difficulties in 
abstinence processes [56-58]. 
 
It has been proposed that E2 may act as a facilitator, at least in part, in the vulnerability to 
drugs of abuse, affecting the brain reward system, which is dependent on the dopaminergic 
transmission from the ventral tegmental area to the nucleus accumbens [59-61]. In 
ovariectomized rodents, the delivery of E2 has been shown to increase cocaine 
consumption, thus suggesting a hormonal-dependent pathway [61, 62]. In addition, Calipari 
et al. (2017) [58] showed that there is an estrous cycle-dependent mechanism controlling 
increased cocaine reward in females, which involves a regulation of the dopamine 
transporter (DAT) via E2 levels. As E2 levels change in an estrous cycle-dependent way, at the 
estrous stage, when E2 levels are high, this hormone increases dopamine activity in the 
ventral tegmental area, leading to conformational changes in DAT via Thr53 
phosphorylation by the ERK kinase.  
 
Cruz et al. (2014) [49] have shown that, in adulthood, rat females neonatally exposed to 
estradiol valerate show alterations in brain areas involved in the production of movement 
and reward, nigrostriatal and mesocorticolimbic pathways, respectively [49]. These authors 
found that, in the striatum and substantial nigra-ventral tegmental area, neurotransmitters 
are altered, showing an increase in dopamine in both areas but only an increase in 
noradrenaline content in the striatum and a decrease in DAT levels. As dopamine is involved 
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in the reward system, they also tested the response to amphetamines in these females 
during adulthood, and proposed that as exposure to estradiol valerate at neonatal life 
exerts changes in the nigrostriatal pathway, then it may affect the rewarding effects when 
these animals are exposed to drugs of abuse. They concluded that exposure to estrogens 
during early life periods may be a factor of vulnerability to drug addiction. 
 
As endocrine disruptors might mimic the action of gonadal steroids, they may affect the 
modulation of the dopaminergic system. For example, it has been shown that BPA 
administration at prenatal and early postnatal life affects the dopamine system, including 
the dopamine receptor and DAT [63]. Thus, BPA may also affect drug reward susceptibility 
and behavioral patterns, but further research is needed to clarify this issue. 
3.- Non-gonadal steroids 
Non-gonadal steroids include corticosteroids, which are lipophilic compounds produced 
mainly in the adrenal glands, although it has been suggested that part of them may also be 
produced in the brain [64, 65]. They act as principal mediators in stress signaling and can be 
divided in two groups: glucocorticoids, among which the most important are cortisol (in 
primates) and corticosterone (in rodents), and mineralocorticoids, such as aldosterone. 
 
 
During late fetal development, corticosteroids play important roles in the development of 
the brain and several other organs. Exposure to these compounds before the late surge 
during gestation may have detrimental effects on the embryo, either through maternal 
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origin (such as corticosterone from maternal origin due to stress) or treatment with 
synthetic glucocorticoids [66]. 
 
Some synthetic glucocorticoids are used during pregnancy either to reduce the risks of early 
premature birth between weeks 24 and 34, as they help in lung maturation, or to manage 
congenital adrenal hyperplasia [67]. One of the common glucocorticoids used in antenatal 
treatment is betamethasone. Its administration is supposed to mimic the fetal surge of 
glucocorticoids and to stimulate fetal lung maturation, thus helping to reduce the morbidity 
and mortality related to respiratory pathologies [67, 68]. Borges et al. (2017) [68] found 
that, in rodents, exposure to betamethasone during gestational days, when the 
reproductive organs are being developed and the brain is becoming sexually mature, leads 
to a low birth weight and affects reproductive outcomes in female offspring, causing 
alterations in the regularity of the estrous cycle, delay of puberty onset, increase in LH 
serum levels, and alterations in the uterine structure. These authors also showed that 
betamethasone alters the sexual behavior of animals, expressed as a reduction of the 
lordosis quotient. Evenmore, betamethasone-treated animals show post-implantation 
problems and a reduced weight of their offspring during in utero life, a marker of 
intrauterine growth alteration[68].  
 
Moisiadis et al. (2017) [66] have shown that prenatal treatment with glucocorticoids leads 
to intergenerational and transgenerational effects on stress-associated behaviors affecting 
the hypothalamic-pituitary-adrenal response to stress, via maternal and paternal 
transmission for at least three generations.  
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Studies in human populations have also shown that administration of glucocorticoids used 
for antenatal treatment is associated with smaller size at birth [69] and neurological and 
behavioral consequences, as these children may present a thinner cortex primarily in the 
rostral anterior cingulate cortex, leukomalacia and high risk of some disorders such as 
hyperactivity and distractibility [70-72]. In a recent study, Kiguti et al. (2017) [73] observed a 
clear male-over-female effect of betamethasone exposure during prenatal life on cardiac 
parameters, and thus suggested that the alterations were sex-dependent. They also 
suggested that the results observed were probably due to the reduced intrauterine T in the 
betamethasone-exposed male progeny. These results highlight, once again, the importance 
of studying the hormonal context in a sex-dependent manner.  
 
4-Endocrine disruptors 
Endocrine disruptors are compounds that may interfere with the endocrine system, causing 
alterations in metabolism, reproduction, brain and behavior changes and other 
neuroendocrine pathways. Besides the endogenous hormones that act programming 
neuroendocrine functions during development, some xenobiotics, environmental and 
chemical substances such as pesticides, fungicides, industrial chemicals, plastics and plant-
derived products (such as. phytoestrogens) can interfere with the hormonal signaling as 
they act as hormone agonists or antagonists via ERs (xenoestrogens) and ARs 
(xenoandrogens) [74]. As endrocrine disruptors are ubiquitous and are part of the daily life, 
they may exert their actions during critical windows of development, leading to 
programming and long-term effects. It is of great interest to study their effects as they can 
be transferred from maternal-fetal interaction as well as via lactation and are also found in 
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food sources [75, 76]. The present review will focus on the case of bisphenols, phthalates 
and parabens, which are found in plastics and in some common pesticides (Figure 4). 
 
4.1 Bisphenols, phtalates and parabens 
Bisphenols, phthalates and parabens are found in plasticizers, solvents and additives. 
Worldwide populations are exposed to these compounds in daily life as they are found in 
several industrial and consumer products, mainly food and drink [77]. One of the most 
common bisphenols is bisphenol A (BPA), which is found in polycarbonate plastic containers, 
including baby bottles. Thus, humans are exposed to BPA since early postnatal periods of 
life. BPA is known to bind competitively to ERs, with high affinity for ERβ, but it can also act 
via estrogen-independent pathways [78].  
 
Phthalates are diesters of phthalic acid, which are used in wrapping materials and food 
processing. Thus, humans are exposed to them throughout life. They act as antiandrogenic 
compounds. In both humans and rodents, there is evidence that exposure to phthalates 
causes developmental and reproductive alterations [79]. There is also evidence that 
mixtures of BPA and phthalates have additive interactions in their antiandrogenic activity, 
showing synergistic effects at high concentrations and antagonistic activities at low 
concentrations [80]. 
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In vitro and in vivo models have shown that alterations mediated by bisphenols and 
phthalates involve epigenetic mechanisms and present intergenerational and 
transgenerational effects. Studies in human populations and animal models have shown 
that BPA levels in pregnant females correlate with increased androgen levels, high levels of 
leptin and low levels of adiponectin (two adipocytokines) [81], nitrosative stress, 
dyslipidemia, liver damage, hormonal imbalance and ovarian dysfunctions in their female 
progeny [82]. It has been shown that PCOS women, independently of their body weight, 
have high levels of serum BPA [83]. Thus, as this compound can mimic the actions of natural 
steroids, it may be considered as a factor involved in the etiopathogenesis of the syndrome. 
In addition, given the evidence of animal models that suggest that BPA exposure may lead 
to PCOS-like features, the high rates of this syndrome nowadays may be also explained by 
the effect of this endocrine disruptor. BPA may also have a role as an environmental 
component in PCOS pathogenesis [83].  
 
Some studies have shown that maternal administration of methyl donors, such as folic acid 
or vitamin B12 [84, 85] during pregnancy or melatonin [86] during early life periods, might 
partly reverse the effects of BPA in the offspring. These results show that the susceptibility 
periods of life for programming should be considered as good windows for medical 
interventions to reverse, at least partially, the detrimental effects of exposure to estrogenic 
and androgenic compounds. 
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Parabens are also found in plastics and in other daily life sources such as cosmetics, 
pharmaceutics and food industries. They are known to have estrogenic activity and can bind 
to ERs. As they are lipophilic, they can cross the brain barrier and accumulate in the skin and 
adipose tissue. It has been shown that the human population presents a high concentration 
of these compounds in serum, urine and breast milk samples [87]. Rodent studies have 
shown that high doses of parabens can affect female fertility and, if the exposure is in utero, 
they can also affect the offspring, acting as endocrine disruptors, being able to cross the 
placenta [88]. In a recent study, Guerra et al. (2017) [89] have shown that exposure during 
prenatal life to low doses of butylparaben does not affect the female offspring reproductive 
parameters but does affect brain sexual development, as they found that over 50% of the 
treated animals were not sexually receptive to males. 
 
As human populations are exposed to these compounds in daily life, it could be of great 
interest to evaluate metabolites of these compounds in pregnant women, so that medical 
interventions and follow-up could be done to their offspring. As mentioned before, 
intervention can include the administration of compounds as melatonin or folic acid, which 
are known not to affect the developing organism and may also have positive effects on 
maternal-fetal health since early life. 
4.2 Pesticides 
Pesticides, as insecticides, herbicides and fungicides, are widely used for agricultural and 
medical purposes. Thus, the worldwide population is at high risk of exposure to pesticides, 
and it has been suggested that some cases of cancer, neurological disorders, poisoning, 
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allergies, and reproductive disorders might be related to pesticide exposure [90]. Moreover, 
although some of them are no longer used, their effects persist in the environment. Thus, 
some authors have studied some of the intergenerational and transgenerational effects of 
some pesticides and found that they are able to act through epigenetic mechanisms. There 
are different classes of pesticides. Some of the most common ones are synthetic 
organochlorine and organophosphorus compounds. Although they are not steroidogenic 
compounds, they share lipophilic and chemical structural similarities, which allow them to 
act via ARs and ERs, either mimicking or inhibiting their action. 
 
-A) Organochlorine pesticides 
Organochlorine pesticides such as dichlorodiphenyltrichloroethane (DDT), methoxychlor 
(MXC) and endosulfan are among the most used pesticides. As most of them have lipophilic 
structures, they may bioaccumulate and persist for years, thus being among the most 
frequent contaminants. Besides, given their structure, they can cross the placenta, thus 
affecting the developing embryos [91]. It has also been shown that they can affect female 
fertility by disrupting the estrous cycle, the development of ovarian follicles and the 
hormone levels [92]. 
 
DDT has been banned in many countries because of its toxic effects, but is still used as 
malaria vector control in some places of Africa [93]. It has been described that DDT may lead 
to developmental and reproductive abnormalities, neurological disorders and cancer [93-
95]. It has also been shown that DDT has transgenerational effects, including ovarian 
diseases, obesity, metabolic alterations and cancer susceptibility in adult life, via epigenetic 
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mechanisms [93, 96, 97]. It has also been reported that exposure to DDT during pregnancy 
leads to subfertility in the female offspring [98].  
 
Since the prohibition of DDT, MXC has been used in its replacement. However, MXC also 
persists in the environment after its use and has been shown to have strong estrogenic and 
anti-androgenic effects [90, 99, 100]. Human epidemiological and rodent model studies 
have shown that constant exposure to MXC during adulthood affects cycling and ovulation 
and leads to fertility issues [99, 101, 102]. Several studies have described that MXC can have 
a developmental programming effect [102-104], causing alterations in epigenetic processes, 
such as changes in methylation patterns [99]. When rodents are exposed to MXC during 
fetal or early postnatal life, the effects in females persist until adulthood, with alterations in 
reproductive outcomes, such as puberty acceleration, irregular estrous cycle and alterations 
in folliculogenesis and cyst formation. The effects of prenatal administration of MXC have 
also been tested in sheep, and results showed that it can alter the LH surge at postnatal life, 
generate cycle disruption, and lead to low birth weight in the female offspring [105]. 
 
Endosulfan has also been found to have long-term effects on the population. It has been 
described as a xenoestrogenic compound that can interact and activate ERs. As endosulfan 
can be stored in adipose tissue, mothers exposed to it during their life may affect their 
children during pregnancy via the placenta and umbilical cord. Endosulfan has also been 
reported to affect fertility as well as glucose metabolism, affecting the pancreas and plasma 
glucose levels, as well as liver oxidative stress and functions [91, 106]. 
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-B) Organophosphorus pesticides 
Organophosphorus pesticides, among which dichlorvos and chlorpyrifos are some of the 
most used, exert their toxicological action via inhibition of the enzyme acetylcholinesterase 
[107]. This enzyme is expressed in several tissues, including the central nervous system and 
the ovary, and participates in the regulation of folliculogenesis [108]. Thus, 
organophosphorus pesticides may be affecting not only the nervous system at brain level 
but also the local ovarian system, but further research is needed to clarify this.  
 
Chlorpyrifos has been shown to have neurotoxic effects, to be able to alter placental tissue, 
and to have negative effects on trophoblast development, neural development as well as on 
ovarian, kidney and liver development [109-111]. The worldwide population is exposed to 
this compound because it is found in the environment, water, fruits and vegetables, but 
women living in agricultural communities are more exposed and may thus accumulate this 
compound, showing high levels of it in urine and blood. In addition, as this compound can 
have intergenerational effects, it is of great importance to be aware of this [112]. In a 
murine model, Mansour and Gamet-Payraste (2016) [110] have shown that the effects of 
the indirect exposure to chlorpyrifos during prenatal and early postnatal life (by lactation) 
could be ameliorated by the administration of vitamin E.  
5.-Conclusions 
Complex diseases are currently one of the main concerns in clinics. Nowadays, human 
populations are exposed to several hormonal and hormone-like compounds as 
environmental pollutants and pharmaceutical compounds. As these pathologies have 
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environmental components among their factors contributing to their etiology, it is of great 
importance in clinical, epidemiological and basic research to be aware of the developmental 
programming notion. As described, although steroids play many physiological actions, their 
excess (or absence) may lead to several pathologies that may affect the neuroendocrine and 
reproductive systems. As there are gender differences in the steroid regulation axis, it is also 
of great importance to deepen the study of the effects caused by steroid imbalances. 
Finally, it would be important to deepen the knowledge of the epigenetic mechanisms of 
action that may lead to intergenerational and transgenerational effects caused by steroid 
derangements, because they can be used as targets for the therapeutics of complex 
pathologies and disorders.     
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Figure 1: Windows of susceptibility to environmental insults that may affect developing 
organisms throughout life. Developmental programming consequences may lead to 
epigenetic and gene expression changes and physiological adaptations that affect the 
susceptibility to adult diseases.  
 
Figure 2: Schematic overview of the main steps of the steroidogenic process. Progestins and 
androgens (Dehydroepiandrosterone=DHEA, androstenedione and testosterone) are part of 
adrenal and ovarian steroidogenesis. Mineralocorticoids (e.g. aldosterone) and 
glucocorticoids (e.g. cortisol and corticosterone) are products of adrenal steroidogenesis, 
whereas estrogens (estradiol and estrone) are products of the ovarian steroidogenic 
process.  
 
Figure 3: Metabolic and reproductive outcomes of different models of developmental 
programming of Polycystic ovary syndrome (PCOS). AMH= anti-Müllerian hormone; GD= 
gestational days; T= testosterone; DHT= dihydrotestosterone; EV=estradiol valerate. The 
pink arrow indicates the offspring. In those cases the exposure to androgen or estrogen is 
directly on the offspring, at postnatal life. 
 
Figure 4: Most common endocrine disruptors and their action during early life 
programming. In purple: Examples of bisphenols, parabens and phtalates. In green: 
Examples of organochlorine pesticides.  In yellow: Examples of organophosphorus 
pesticides. 
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